ICH GCP US Clinical Trials Registry Clinical Tri
Post# of 154868
(Total Views: 373)
Posted On: 07/01/2025 4:38:15 PM
ICH GCP
US Clinical Trials Registry
Clinical Trial NCT06699836
A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC
May 7, 2025 updated by: CytoDyn, Inc.
Source read in full a lot of info in the study
https://ichgcp.net/clinical-trials-registry/NCT06699836
US Clinical Trials Registry
Clinical Trial NCT06699836
A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC
May 7, 2025 updated by: CytoDyn, Inc.
Source read in full a lot of info in the study
https://ichgcp.net/clinical-trials-registry/NCT06699836
(2)
(0)